SCHEMBL29780934

SCHEMBL29780934

[2H]c1nn(C2CCC3(CC2)OCCO3)c2ncnc(N)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.37
▸ BTK Q06187 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ RET P07949 2/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ NTRK1 P04629 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ ROS1 P08922 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30513350 0.73 JAK2 (0.54) EGFRRETMAPK1CDC7PLK4
SCHEMBL29617723 0.73 RET (0.64) EGFRRETMAPK1CDC7PLK4
SCHEMBL5814550 0.73 JAK2 (0.54) EGFRRETMAPK1CDC7PLK4
SCHEMBL5805110 0.73 RET (0.64) EGFRRETMAPK1CDC7PLK4
SCHEMBL29780932 0.71 EGFR (0.42) EGFRBTKLCKSRCKDR
SCHEMBL23847697 0.71 ADK (0.48) EGFRRETMAP4K4LCKFYN
SCHEMBL1443714 0.71 ADK (0.54) EGFRRAB9ARETMAP4K4LCK
SCHEMBL30563711 0.71 EGFR (0.38) EGFRBTKRETMAPK1CDC7
SCHEMBL29886844 0.70 EGFR (0.50) EGFRBTKALDH1A1RETLCK
SCHEMBL20744975 0.70 EGFR (0.55) EGFRBTKALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022166610-A1 PYRIDAZINONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-08-11 — — WO disclosed
Send feedback